Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Genes Dev ; 27(7): 719-24, 2013 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-23520387

RESUMEN

Cellular reprogramming-the ability to interconvert distinct cell types with defined factors-is transforming the field of regenerative medicine. However, this phenomenon has rarely been observed in vivo without exogenous factors. Here, we report that activation of Notch, a signaling pathway that mediates lineage segregation during liver development, is sufficient to reprogram hepatocytes into biliary epithelial cells (BECs). Moreover, using lineage tracing, we show that hepatocytes undergo widespread hepatocyte-to-BEC reprogramming following injuries that provoke a biliary response, a process requiring Notch. These results provide direct evidence that mammalian regeneration prompts extensive and dramatic changes in cellular identity under injury conditions.


Asunto(s)
Células Epiteliales/citología , Hepatocitos/citología , Regeneración Hepática/fisiología , Animales , Linaje de la Célula , Células Epiteliales/metabolismo , Hepatocitos/metabolismo , Ratones , Receptores Notch/metabolismo , Transducción de Señal , Células Madre/citología
2.
Gastroenterology ; 146(3): 647-51, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24333829

RESUMEN

Hematogenous dissemination is thought to be a late event in cancer progression. We recently showed in a genetic model of pancreatic ductal adenocarcinoma that pancreas cells can be detected in the bloodstream before tumor formation. To confirm these findings in humans, we used microfluidic geometrically enhanced differential immunocapture to detect circulating pancreas epithelial cells in patient blood samples. We captured more than 3 circulating pancreas epithelial cells/mL in 7 of 21 (33%) patients with cystic lesions and no clinical diagnosis of cancer (Sendai criteria negative), 8 of 11 (73%) with pancreatic ductal adenocarcinoma, and in 0 of 19 patients without cysts or cancer (controls). These findings indicate that cancer cells are present in the circulation of patients before tumors are detected, which might be used in risk assessment.


Asunto(s)
Células Epiteliales/patología , Células Neoplásicas Circulantes/patología , Páncreas/patología , Quiste Pancreático/diagnóstico , Quiste Pancreático/patología , Adenocarcinoma/diagnóstico , Adenocarcinoma/patología , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Ductal Pancreático/diagnóstico , Carcinoma Ductal Pancreático/patología , Estudios de Casos y Controles , Femenino , Técnica del Anticuerpo Fluorescente , Humanos , Masculino , Técnicas Analíticas Microfluídicas , Persona de Mediana Edad , Proyectos Piloto , Estudios Prospectivos , Medición de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA